The rapid tests market size has grown rapidly in recent years. It will grow from $34.67 billion in 2025 to $38.66 billion in 2026 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to increasing demand for rapid disease detection, technological advancements in lateral flow assays, rising awareness about preventive healthcare, expansion of healthcare infrastructure in emerging economies, growing prevalence of infectious diseases.
The rapid tests market size is expected to see rapid growth in the next few years. It will grow to $59.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to integration of ai and iot in rapid tests, rising adoption of home healthcare solutions, development of multiplex testing kits, expansion of personalized medicine, government initiatives supporting point-of-care diagnostics. Major trends in the forecast period include point-of-care testing expansion, miniaturization of diagnostic devices, rapid infectious disease screening, home-based diagnostic solutions, cost-effective testing solutions.
The growing number of infectious disease cases is contributing to the expansion of the rapid tests market. These diseases, caused by harmful organisms such as bacteria, viruses, fungi, or parasites, are easily transmitted between individuals. Increasing global mobility contributes to the faster spread of such pathogens. Rapid testing solutions play a critical role by providing accurate and timely diagnoses at the point of care, allowing healthcare providers to initiate treatment and containment measures promptly. They play an essential role in reducing diagnostic delays, enhancing disease response efforts, and curbing infection transmission. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 cases in 2022 to 4,850 in 2023. This trend underscores how the rise in infectious diseases is accelerating the growth of the rapid tests market.
Leading companies in the rapid tests market are developing high-tech solutions like bioluminescence-based technologies that allow for quicker and more sensitive microbial detection. These advanced techniques use biochemical reactions that emit light, generally involving luciferase enzymes and specific substrates, to identify microorganisms or biological indicators. For instance, in March 2025, Nelson Labs, a US-based provider of testing services, introduced a rapid sterility testing method. This approach shortens the traditional 14-day incubation time to just six days using bioluminescence to detect microbial ATP - an indicator of living organisms - by capturing the emitted light during the reaction. The system automates microbial contamination detection, boosts testing precision, ensures compliance with regulations, and allows for quicker product release without compromising safety.
In June 2023, Avacta Group plc, a UK-based life sciences firm, completed the acquisition of Coris Bioconcept SRL for $13.21 million (£10.4 million). This acquisition allowed Avacta to broaden its footprint in the rapid diagnostics sector, enhance its capabilities in in vitro diagnostics (IVD), and leverage Coris’s well-established portfolio of lateral flow tests and its international distribution channels. Coris Bioconcept SRL is a Belgium-based company specializing in the development and supply of rapid diagnostic tests.
Major companies operating in the rapid tests market are F Hoffmann La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens Healthineers, BioMerieux SA, Quidel Corporation, Bio Rad Laboratories Inc, PerkinElmer Inc, OraSure Technologies Inc, SEKISUI Diagnostics LLC, Trivitron Healthcare Pvt Ltd, Ellume Limited, Access Bio Inc, ACON Laboratories Inc, CTK Biotech Inc, iHealth Labs Inc, Wondfo USA Co Ltd, InBios International Inc, Lab Care Diagnostics India Pvt Ltd, Immunostics Inc, Aptitude Medical Systems Inc, Beijing Hotgen Biotech Co Ltd, CorDx Inc, Maxim Biomedical Inc, OSANG LLC.
North America was the largest region in the rapid tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rapid tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the rapid tests market by increasing import costs of diagnostic instruments and consumables, leading to higher overall product pricing and slowed adoption in cost-sensitive regions. Segments like PCR-based instruments and immunoassay-based consumables, particularly in North America and Europe, are most affected due to reliance on imported components. However, tariffs have also encouraged local manufacturing and sourcing strategies, potentially driving innovation and cost optimization in domestic production, creating a more resilient supply chain.
The rapid tests market research report is one of a series of new reports that provides rapid tests market statistics, including rapid tests industry global market size, regional shares, competitors with a rapid tests market share, detailed rapid tests market segments, market trends and opportunities, and any further data you may need to thrive in the rapid tests industry. This rapid tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Rapid tests are diagnostic tools used for the quick detection of specific diseases or conditions, often delivering results within minutes to an hour. These tests do not require complex laboratory infrastructure, making them convenient and accessible. They are user-friendly, need minimal equipment, and can be administered at the point of care - such as clinics, pharmacies, or even at home. The primary function of rapid tests is to support immediate diagnostic decisions, enabling prompt treatment and aiding in disease control.
The main categories of rapid tests include instruments, consumables, and others. Instruments are devices used to analyze samples and encompass portable analyzers, benchtop analyzers, handheld devices, scanners or readers, and multiplex analyzers. These instruments are used to detect contaminants like pathogens, allergens, meat speciation, and pesticides, utilizing various technological methods such as polymerase chain reaction (PCR), immunoassay-based techniques, chromatography-based approaches, and spectroscopy-based tools. Rapid tests are widely used in cardiology, oncology, pregnancy and fertility, toxicology, glucose monitoring, infectious diseases, and more. The major end users of these tests include hospitals and clinics, diagnostic labs, home care settings, and other healthcare environments.
The rapid tests market consists of revenues earned by entities by providing services such as point-of-care diagnostics, on-site screening, home-based testing, mobile health testing units, and diagnostic support for early disease detection and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The rapid tests market also includes sales of rapid diagnostic kits, test strips, reagents, lateral flow assays, analyzers, and related consumables used for the detection of various diseases and conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The rapid tests market size is expected to see rapid growth in the next few years. It will grow to $59.06 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to integration of ai and iot in rapid tests, rising adoption of home healthcare solutions, development of multiplex testing kits, expansion of personalized medicine, government initiatives supporting point-of-care diagnostics. Major trends in the forecast period include point-of-care testing expansion, miniaturization of diagnostic devices, rapid infectious disease screening, home-based diagnostic solutions, cost-effective testing solutions.
The growing number of infectious disease cases is contributing to the expansion of the rapid tests market. These diseases, caused by harmful organisms such as bacteria, viruses, fungi, or parasites, are easily transmitted between individuals. Increasing global mobility contributes to the faster spread of such pathogens. Rapid testing solutions play a critical role by providing accurate and timely diagnoses at the point of care, allowing healthcare providers to initiate treatment and containment measures promptly. They play an essential role in reducing diagnostic delays, enhancing disease response efforts, and curbing infection transmission. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 cases in 2022 to 4,850 in 2023. This trend underscores how the rise in infectious diseases is accelerating the growth of the rapid tests market.
Leading companies in the rapid tests market are developing high-tech solutions like bioluminescence-based technologies that allow for quicker and more sensitive microbial detection. These advanced techniques use biochemical reactions that emit light, generally involving luciferase enzymes and specific substrates, to identify microorganisms or biological indicators. For instance, in March 2025, Nelson Labs, a US-based provider of testing services, introduced a rapid sterility testing method. This approach shortens the traditional 14-day incubation time to just six days using bioluminescence to detect microbial ATP - an indicator of living organisms - by capturing the emitted light during the reaction. The system automates microbial contamination detection, boosts testing precision, ensures compliance with regulations, and allows for quicker product release without compromising safety.
In June 2023, Avacta Group plc, a UK-based life sciences firm, completed the acquisition of Coris Bioconcept SRL for $13.21 million (£10.4 million). This acquisition allowed Avacta to broaden its footprint in the rapid diagnostics sector, enhance its capabilities in in vitro diagnostics (IVD), and leverage Coris’s well-established portfolio of lateral flow tests and its international distribution channels. Coris Bioconcept SRL is a Belgium-based company specializing in the development and supply of rapid diagnostic tests.
Major companies operating in the rapid tests market are F Hoffmann La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens Healthineers, BioMerieux SA, Quidel Corporation, Bio Rad Laboratories Inc, PerkinElmer Inc, OraSure Technologies Inc, SEKISUI Diagnostics LLC, Trivitron Healthcare Pvt Ltd, Ellume Limited, Access Bio Inc, ACON Laboratories Inc, CTK Biotech Inc, iHealth Labs Inc, Wondfo USA Co Ltd, InBios International Inc, Lab Care Diagnostics India Pvt Ltd, Immunostics Inc, Aptitude Medical Systems Inc, Beijing Hotgen Biotech Co Ltd, CorDx Inc, Maxim Biomedical Inc, OSANG LLC.
North America was the largest region in the rapid tests market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rapid tests market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the rapid tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the rapid tests market by increasing import costs of diagnostic instruments and consumables, leading to higher overall product pricing and slowed adoption in cost-sensitive regions. Segments like PCR-based instruments and immunoassay-based consumables, particularly in North America and Europe, are most affected due to reliance on imported components. However, tariffs have also encouraged local manufacturing and sourcing strategies, potentially driving innovation and cost optimization in domestic production, creating a more resilient supply chain.
The rapid tests market research report is one of a series of new reports that provides rapid tests market statistics, including rapid tests industry global market size, regional shares, competitors with a rapid tests market share, detailed rapid tests market segments, market trends and opportunities, and any further data you may need to thrive in the rapid tests industry. This rapid tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Rapid tests are diagnostic tools used for the quick detection of specific diseases or conditions, often delivering results within minutes to an hour. These tests do not require complex laboratory infrastructure, making them convenient and accessible. They are user-friendly, need minimal equipment, and can be administered at the point of care - such as clinics, pharmacies, or even at home. The primary function of rapid tests is to support immediate diagnostic decisions, enabling prompt treatment and aiding in disease control.
The main categories of rapid tests include instruments, consumables, and others. Instruments are devices used to analyze samples and encompass portable analyzers, benchtop analyzers, handheld devices, scanners or readers, and multiplex analyzers. These instruments are used to detect contaminants like pathogens, allergens, meat speciation, and pesticides, utilizing various technological methods such as polymerase chain reaction (PCR), immunoassay-based techniques, chromatography-based approaches, and spectroscopy-based tools. Rapid tests are widely used in cardiology, oncology, pregnancy and fertility, toxicology, glucose monitoring, infectious diseases, and more. The major end users of these tests include hospitals and clinics, diagnostic labs, home care settings, and other healthcare environments.
The rapid tests market consists of revenues earned by entities by providing services such as point-of-care diagnostics, on-site screening, home-based testing, mobile health testing units, and diagnostic support for early disease detection and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The rapid tests market also includes sales of rapid diagnostic kits, test strips, reagents, lateral flow assays, analyzers, and related consumables used for the detection of various diseases and conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Rapid Tests Market Characteristics
3. Rapid Tests Market Supply Chain Analysis
4. Global Rapid Tests Market Trends and Strategies
5. Rapid Tests Market Analysis of End Use Industries
7. Global Rapid Tests Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Rapid Tests Total Addressable Market (TAM) Analysis for the Market
9. Rapid Tests Market Segmentation
10. Rapid Tests Market Regional and Country Analysis
11. Asia-Pacific Rapid Tests Market
12. China Rapid Tests Market
13. India Rapid Tests Market
14. Japan Rapid Tests Market
15. Australia Rapid Tests Market
16. Indonesia Rapid Tests Market
17. South Korea Rapid Tests Market
18. Taiwan Rapid Tests Market
19. South East Asia Rapid Tests Market
20. Western Europe Rapid Tests Market
21. UK Rapid Tests Market
22. Germany Rapid Tests Market
23. France Rapid Tests Market
24. Italy Rapid Tests Market
25. Spain Rapid Tests Market
26. Eastern Europe Rapid Tests Market
27. Russia Rapid Tests Market
28. North America Rapid Tests Market
29. USA Rapid Tests Market
30. Canada Rapid Tests Market
31. South America Rapid Tests Market
32. Brazil Rapid Tests Market
33. Middle East Rapid Tests Market
34. Africa Rapid Tests Market
36. Rapid Tests Market Competitive Landscape and Company Profiles
37. Rapid Tests Market Other Major and Innovative Companies
40. Rapid Tests Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Rapid Tests Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses rapid tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for rapid tests? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rapid tests market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Consumables; Other Products2) By Contaminants: Pathogens; Allergens
3) By Technology: Polymerase Chain Reaction (PCR)-Based; Immunoassay-Based; Chromatography-Based
4) By Application: Cardiology; Oncology; Pregnancy And Fertility; Toxicology; Glucose Monitoring; Infectious Disease; Other Applications
5) By End User: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End-Users
Subsegments:
1) By Instruments: Portable Analyzers; Benchtop Analyzers; Handheld Devices; Readers Or Scanners; Multiplex Analyzers2) By Consumables: Test Strips; Test Cassettes Or Cartridges; Reagents; Sample Collection Devices; Control And Calibration Materials
3) By Other Products: Software And Data Management Systems; Accessories; Maintenance And Service Kits
Companies Mentioned: F Hoffmann La Roche AG; Abbott Laboratories; Thermo Fisher Scientific Inc; Siemens Healthineers; BioMerieux SA; Quidel Corporation; Bio Rad Laboratories Inc; PerkinElmer Inc; OraSure Technologies Inc; SEKISUI Diagnostics LLC; Trivitron Healthcare Pvt Ltd; Ellume Limited; Access Bio Inc; ACON Laboratories Inc; CTK Biotech Inc; iHealth Labs Inc; Wondfo USA Co Ltd; InBios International Inc; Lab Care Diagnostics India Pvt Ltd; Immunostics Inc; Aptitude Medical Systems Inc; Beijing Hotgen Biotech Co Ltd; CorDx Inc; Maxim Biomedical Inc; OSANG LLC
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Rapid Tests market report include:- F Hoffmann La Roche AG
- Abbott Laboratories
- Thermo Fisher Scientific Inc
- Siemens Healthineers
- BioMerieux SA
- Quidel Corporation
- Bio Rad Laboratories Inc
- PerkinElmer Inc
- OraSure Technologies Inc
- SEKISUI Diagnostics LLC
- Trivitron Healthcare Pvt Ltd
- Ellume Limited
- Access Bio Inc
- ACON Laboratories Inc
- CTK Biotech Inc
- iHealth Labs Inc
- Wondfo USA Co Ltd
- InBios International Inc
- Lab Care Diagnostics India Pvt Ltd
- Immunostics Inc
- Aptitude Medical Systems Inc
- Beijing Hotgen Biotech Co Ltd
- CorDx Inc
- Maxim Biomedical Inc
- OSANG LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 38.66 Billion |
| Forecasted Market Value ( USD | $ 59.06 Billion |
| Compound Annual Growth Rate | 11.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
